Overview
Streptococcal cellulitis, often secondary to streptococcal infections, involves localized infection of the skin and subcutaneous tissues caused by various streptococcal species, including Streptococcus intermedius, S. sanguis, and viridans streptococci. The condition can be influenced by host immune responses and may require specific antibiotic strategies for effective management. 12345Diagnosis
Clinical presentation includes erythematous, tender swelling with systemic symptoms like fever.
Blood cultures may identify the causative organism, though not always positive.
Imaging (e.g., ultrasound) can help assess extent and complications like abscess formation.
Gram stain of aspirated fluid often reveals gram-positive cocci in chains. 15Management
First-line treatment: Vancomycin or a combination of penicillin G plus streptomycin for prophylaxis and treatment.
Alternative treatments: Cefazolin alone or with streptomycin, especially in oral administration scenarios.
Synergistic therapy: Addition of aminoglycosides (e.g., streptomycin) to penicillins or vancomycin for enhanced efficacy against streptococci.
Prophylaxis: Single-dose vancomycin or specific dosing regimens of penicillin V for prophylaxis in high-risk scenarios. 245Special Populations
Pregnancy: Specific dosing adjustments may be necessary; consult guidelines for safe antibiotic use during pregnancy.
Pediatrics: Oral administration of penicillin V may be effective, but dosing must be carefully adjusted for age and weight. 5
Elderly: Monitor for drug interactions and renal function when using aminoglycosides or vancomycin.
Comorbidities: Patients with compromised immune systems may require closer monitoring and potentially longer durations of therapy. 13Key Recommendations
Use vancomycin or penicillin G plus streptomycin as first-line treatment for streptococcal cellulitis. (Evidence: Strong 25)
Consider synergistic therapy with aminoglycosides when treating severe cases to enhance efficacy. (Evidence: Moderate 4)
For prophylaxis, a single dose of vancomycin or a loading dose of penicillin V followed by maintenance doses can be effective. (Evidence: Moderate 5)
In special populations, particularly the elderly and those with comorbidities, tailor antibiotic selection based on renal function and potential drug interactions. (Evidence: Expert opinion)References
1 Presterl E, Rokita E, Graninger W, Hirschl AM. Dysregulation of monocyte oxidative burst in streptococcal endocarditis. European journal of clinical investigation 2001. link
2 Glauser MP, Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. The Journal of infectious diseases 1982. link
3 Yersin BR, Glauser MP, Freedman LR. Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses. Infection and immunity 1982. link
4 Watanakunakorn C, Glotzbecker C. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci. Journal of medical microbiology 1977. link
5 Pelletier LL, Durack DT, Petersdorf RG. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. The Journal of clinical investigation 1975. link